INVITED SPEAKERS
Robert C. King, PhD
Partner at Goldman Sachs International and Global Vice Chairman, Investment Banking Division
Amy W. Schulman
Managing Partner, LS Polaris Innovation Fund and Polaris Partners
Todd Brinton, MD
Corporate Vice President, Advanced Technology and Chief Scientific Officer, Edwards Lifesciences
Tom Sudow
Director, Business Development, Cleveland Clinic Innovations
Mark D. Stovsky, MD, MBA, FACS
Senior Director, Emerging Business, Cleveland Clinic Ventures
Jeroen Tas
Chief Innovation & Strategy Officer, Philips
Aharon Aharon
CEO, Israel Innovation Authority
Francois Maisonrouge
Senior Managing Director, Evercore Partners
Fiona de Hemptinne
Venture Partner, UCB Ventures
Miriam Frieden, PhD, MBA
VP of Search and Evaluation, Novo Nordisk
Tina Xu
Vice President of Information Technology and Head of Business Innovation, AstraZeneca, China
Laurent Choppe, DVM
Managing Partner, Cukierman & Co. Life Sciences
Zafrira Avnur, PhD
CSO & Partner, VP Quark Venture Inc.
Max Zeiberg
Corporate Development, Gilead Sciences
Aya Jakobovits, PhD
Founder, Director, Adicet Bio
Erez Chimovits
Senior Managing Director, OrbiMed Advisors
Anat Naschitz
Managing Director, OrbiMed Advisors
Irit Yaniv, MD
General Partner, Accelmed
Ron Ginor, MD
Venture Partner, OrbiMed Advisors
Naomi Gefen
Deputy Director General, ALYN Hospital
Prof. Yael Hanein, PhD
School of Electrical Engineering, Tel Aviv University
Yaron Daniely, PhD
CEO, Yissum
Yael Weiss, MD, PhD
Vice President Business Development, Ultragenyx
Stephen Squinto, PhD
Interim CEO, Passage Bio
Prof. David Sidransky, MD
Johns Hopkins School of Medicine; Co-Founder and General Partner, Israel Biotech Fund
Prof. Varda Shalev, MD, MPA
Managing Director, Morris Kahn & Maccabi Research and Innovation Institute at Maccabi Health Care Services
Yair Schindel, MD
Co-Founder & Managing Partner, aMoon Fund
Allen Kamer
Managing Partner, OurCrowd Qure
Prof. Simon Benita, PhD
Head of Nano Delivery Systems, Hebrew University of Jerusalem
Ayelet Torem, Adv.
Partner, Hi-Tech & Venture Capital and Head of Global Markets, Amit, Pollak, Matalon & Co
Dorman Followwill
Senior Partner, Frost & Sullivan
Prof. Nadav Ahituv, PhD
Department of Bioengineering and Therapeutic Science, University of California San Francisco
Rachel Haurwitz, PhD
Co-founder, President and CEO, Caribou Biosciences
Ulrich Brinkmann, PhD
Scientific Director, Roche Pharma Research & Early Development, Roche Diagnostics GmbH
Michal J. Besser, PhD
Head of Laboratory, Ella Lemelbaum Institute for Immuno Oncology & Director, Wohl GMP Facility, Sheba Medical Center; Assistant Professor, Dept. of Microbiology and Immunology, School of Medicine, Tel Aviv University
Adi Barzel, PhD
Senior Lecturer, Department of Biochemistry at Tel Aviv University; Co-Founder of LogicBio Therapeutics, Inc.; President of the Israeli Society of Gene and Cell Therapy
Bruce R. Rosengard, MD
VP, Global External Innovation, Johnson and Johnson Medical Devices
John J. Smith, MD
Partner, Hogan Lovells
Prof. Elizabeth Croydon
Senior Clinical Director, Oncology – EU Clinical Development, Merck Sharp & Dohme
Trevor Martin, PhD
CEO and Co-Founder, Mammoth Biosciences
Elliot Menschik, MD, PhD
Global Head, Healthcare + Life Science Startups, Amazon Web Services
Kelly Krajnik
Senior Manager, Devices, Diagnostics, Mayo Clinic Ventures
Prof. Eitan Friedman, MD, PhD
Director & Founder of The Suzanne Levy-Gertner Oncogenetics Unit, Sheba Medical Center
Michal Rosen-Zvi
Director, Healthcare Informatics, IBM Research
Wade Ackerman
FDA Regulatory group, Co-Lead of Digital Health Initiative, Covington & Burling LLP
Gary Gordon, MD, PhD
Former Vice President, Global Oncology Development, AbbVie, Inc
Prof. Joel V. Brill, MD, FACP
Chief Medical Officer, Predictive Health. LLC
Prof. Yaakov Nahmais, PhD
Director, Grass Center for Bioengineering, The Hebrew University of Jerusalem
Prof. David Mirelman, PhD
Weizmann Institute of Science
Prof. Daniel Offen, PhD
Tel Aviv University
Prof. Gal Markel, MD, PhD
Tel Aviv University
Eran Stark, MD, PhD
Sackler Faculty of Medicine, Tel Aviv University
Carl L. Gordon, PhD
Managing Partner, OrbiMed Advisors
Nicholas Pachuda
WW Vice President, Orthopedic Innovation, J&J Medical Devices
Eric Tansky
Managing Director, Oppenheimer & Co. Inc.
Prof. Hinanit Koltai, PhD
Agricultural Research Organization (ARO), Volcani Center
Prof. Raphael Mechoulam, PhD
Hebrew University of Jerusalem
Prof. Itamar Raz, MD
Head, The Israeli National Diabetes Council
Medy Wiener
Chief Medical Officer, BOL Pharma
Hadas Bitran
Head of Healthcare Israel, Microsoft
Ziv Ofek
Founder and CEO, MDClone
Tamara Mansfeld
Global Innovation Lead, Pfizer
Leif E. Pedersen
CEO, Dassault Systemes BIOVIA
Don Mathis
General Manager, Growth Comcast NBCUniversal
Prof. Angel Porgador, PhD
Ben Gurion University
Prof. Ofer Mandelboim, PhD
Hebrew University of Jerusalem
Maurit Beeri, MD
Director General, ALYN Hospital
Sagit Arbel-Alon, MD
Deputy Director, Reuth Medical & Rehabilitation Hospital
Yoav Medan, PhD
Yaron Galitzky
General Manager, Devices and Accessories, Microsoft
Ziv Shilon
Co-founder, COO, 6Degrees
Itamar Offer, MD, MPA
CEO, Sabar Health
Aviv Zeevi, PhD
VP, Technology Infrastructure, Israel Innovation Authority
Prof. Tal Dvir, PhD
Tel Aviv University
Regine Shevach
Managing Director, Inter-Lab, an affiliate of Merck KGaA
Shai Policker
CEO, Medex Xelerator LP
Avinatan Hassidim
Head of TLV Research, Google
Uma Makhija
Business Development Lead, Digital Health, Otsuka Pharmaceuticals
Ronald G. Crystal, MD
Founder, LEXEO Therapeutics and Chair, Department of Genetic Medicine, Weill Cornell Medical College
